EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

The Opioid Analgesic Reduction Study (OARS) Pilot: A Double-Blind Randomized Multicenter Trial

C A Feldman iD, J Fredericks-Younger, P J Desjardins, H Malmstrom, M Miloro, G Warburton, B Ward, V Ziccardi, D H Fine, P Greenberg, T Andrews, P B Matheson und 1 weitere

JDR Clinical & Translational Research · 2024

DOI: 10.1177/23800844221144031 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JDR Clinical & Translational Research, 2024. Verfasst von C A Feldman und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Dental Medicine, Rutgers University, Newark, NJ, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With addiction rates and opioid deaths increasing, health care providers are obligated to help stem the opioid crisis. As limited studies examine the comparative effectiveness of fixed-dose combination nonopioid analgesia to opioid-containing analgesia, a comparative effectiveness study was planned and refined by conducting a pilot study.

Methods

The Opioid Analgesic Reduction Study (OARS) pilot, a stratified, randomized, multisite, double-blind clinical trial, was designed to test technology and procedures to be used in the full OARS trial. Participants engaged in the full protocol, enabling the collection of OARS outcome data. Eligible participants reporting to 1 of 5 sites for partial or full bony impacted mandibular third molar extraction were stratified by biologic sex and randomized to 1 of 2 treatment groups, OPIOID or NONOPIOID. OPIOID participants were provided 20 doses of hydrocodone 5 mg/acetaminophen 300 mg. NONOPIOID participants were provided 20 doses of ibuprofen 400 mg/acetaminophen 500 mg. OARS outcomes data, including pain experience, adverse effects, sleep quality, pain interference, overall satisfaction, and remaining opioid tablets available for diversion, were collected via surveys, electronic medication bottles, eDiary, and activity/sleep monitor.

Results

Fifty-three participants were randomized with 50 completing the OARS pilot protocol. Across all outcome pain domains, in all but 1 time period, NONOPIOID was better in managing pain than OPIOID ( P < 0.05 level). Other outcomes suggest less pain interference, less adverse events, better sleep quality, better overall satisfaction, and fewer opioid-containing tablets available for diversion.

Discussion

Results suggest patients requiring impacted mandibular third molar extraction would benefit from fixed-dose combination nonopioid analgesia. Knowledge Transfer Statement: Study results suggest fixed-dose nonopioid combination ibuprofen 400 mg/acetaminophen 500 mg is superior to opioid-containing analgesic (hydrocodone 5 mg/acetaminophen 500 mg). This knowledge should inform surgeons and patients in the selection of postsurgical analgesia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidAnalgesics, Non-NarcoticHumansAcetaminophenIbuprofenHydrocodonePilot ProjectsDrug CombinationsPainDouble-Blind Method

Stichwörter der Autor:innen

acetaminophenclinical trialhydrocodoneibuprofenoral and maxillofacial surgerypain

Substanzen

Analgesics, OpioidAcetaminophenIbuprofenHydrocodoneDrug CombinationsAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • School of Dental Medicine, Rutgers University, Newark, NJ, USA.
  • School of Public Health, Rutgers University, Newark, NJ, USA.
  • Eastman Institute for Oral Health, University of Rochester, Rochester, NY, USA.
  • College of Dentistry, University of Illinois, IL, USA.
  • School of Dentistry, University of Maryland, MD, USA.
  • School of Dentistry, University of Michigan, MI, USA.

ORCID-Profile: C A Feldman

Förderung

  • NIDCR NIH HHS
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Feldman, C. A., Fredericks-Younger, J., Desjardins, P. J., Malmstrom, H., Miloro, M., Warburton, G., Ward, B., Ziccardi, V., Fine, D. H., Greenberg, P., Andrews, T., Matheson, P. B., & Lu, S. E. (2024). The Opioid Analgesic Reduction Study (OARS) Pilot: A Double-Blind Randomized Multicenter Trial. JDR Clinical & Translational Research. https://doi.org/10.1177/23800844221144031

Vancouver

Feldman CA, Fredericks-Younger J, Desjardins PJ, Malmstrom H, Miloro M, Warburton G, et al. The Opioid Analgesic Reduction Study (OARS) Pilot: A Double-Blind Randomized Multicenter Trial. JDR Clinical & Translational Research. 2024. doi:10.1177/23800844221144031

BibTeX
@article{Feldman2024,
  author = {Feldman, C A and Fredericks-Younger, J and Desjardins, P J and Malmstrom, H and Miloro, M and Warburton, G and Ward, B and Ziccardi, V and Fine, D H and Greenberg, P and Andrews, T and Matheson, P B and Lu, S-E},
  title = {The Opioid Analgesic Reduction Study (OARS) Pilot: A Double-Blind Randomized Multicenter Trial},
  journal = {JDR Clinical & Translational Research},
  year = {2024},
  doi = {10.1177/23800844221144031}
}
Kostenlos starten →